Steward Medical Group, INC
Steward Medical Group, INC was paid $4.92M by Medicaid between Jan 2018 and Sep 2024, across 116 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 27% of everything it billed.
33Billing provider infoSTEWARD MEDICAL GROUP, INC
BRIGHTON, MA 02135
BRIGHTON, MA 02135
33aNPI1013220151assigned 07/19/2010
33bProvider typeSpecialist
28Total paid$4.92M
24GClaims573,942
24DCodes billed116
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Specialist providers in Massachusetts
Rank by total paid#4 of 179
Median peer was paid$23K
This provider vs. median212×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,526 | $352K | |
| 2019 | 13,181 | $301K | |
| 2020 | 7,953 | $230K | |
| 2021 | 44,442 | $602K | |
| 2022 | 106,537 | $1.15M | |
| 2023 | 333,661 | $2.06M | |
| 2024incomplete | 55,642 | $224K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 27% | 46,845 | 40,476 | $1.33M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 8,885 | 7,878 | $633K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.4% | 87,710 | 52,192 | $461K |
| ATP14 | 5.8% | 25,919 | 21,490 | $286K | |
| 88342 | 5.6% | 13,152 | 12,224 | $276K | |
| 84484 | 3.6% | 17,324 | 13,731 | $180K | |
| 88307 | 3.3% | 2,615 | 2,542 | $160K | |
| 83735 | 2.6% | 29,121 | 12,045 | $129K | |
| ATP08 | 2.5% | 14,107 | 9,520 | $125K | |
| 80053 | Comprehensive metabolic panel | 1.6% | 53,623 | 38,724 | $77K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 6,495 | 6,017 | $71K |
| 83690 | 1.3% | 11,960 | 10,635 | $64K |
104 more codes
| 84702 | 1.3% | 4,791 | $62K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 9,580 | $59K |
| 83880 | 1.2% | 4,695 | $57K | |
| 87040 | 1.1% | 4,578 | $56K | |
| ATP15 | 1.1% | 5,022 | $55K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 41,773 | $47K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,270 | $43K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,464 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,228 | $43K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 869 | $41K |
| 81001 | <1% | 17,349 | $41K | |
| 85610 | <1% | 12,602 | $36K | |
| 85027 | <1% | 8,021 | $36K | |
| 88341 | <1% | 1,126 | $35K | |
| 88304 | <1% | 4,514 | $31K | |
| 85730 | <1% | 5,060 | $25K | |
| 81003 | <1% | 13,202 | $22K | |
| ATP09 | <1% | 2,262 | $21K | |
| 82607 | <1% | 2,027 | $20K | |
| 82728 | <1% | 2,028 | $20K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,193 | $18K |
| 85379 | <1% | 2,207 | $17K | |
| 87077 | <1% | 2,556 | $17K | |
| 87186 | <1% | 2,376 | $17K | |
| 82947 | <1% | 24,004 | $15K | |
| 82746 | <1% | 1,533 | $15K | |
| 87070 | <1% | 2,366 | $14K | |
| 81025 | <1% | 6,577 | $14K | |
| ATP17 | <1% | 1,190 | $13K | |
| 88141 | <1% | 685 | $13K | |
| ATP16 | <1% | 1,129 | $12K | |
| ATP02 | <1% | 2,040 | $11K | |
| 88312 | <1% | 622 | $10K | |
| 83540 | <1% | 1,952 | $9K | |
| 87081 | <1% | 1,611 | $8K | |
| 88313 | <1% | 1,027 | $8K | |
| ATP18 | <1% | 660 | $7K | |
| ATP04 | <1% | 986 | $7K | |
| 87205 | <1% | 2,105 | $7K | |
| 86592 | <1% | 1,923 | $7K | |
| 82570 | <1% | 2,590 | $7K | |
| 86803 | <1% | 481 | $6K | |
| 82803 | <1% | 456 | $6K | |
| 84100 | <1% | 11,927 | $5K | |
| 80202 | <1% | 546 | $5K | |
| 84439 | <1% | 694 | $5K | |
| 80076 | <1% | 4,500 | $4K | |
| 85652 | <1% | 1,992 | $4K | |
| ATP03 | <1% | 555 | $4K | |
| 87340 | <1% | 449 | $4K | |
| 82140 | <1% | 558 | $4K | |
| 84165 | <1% | 693 | $3K | |
| 82330 | <1% | 456 | $3K | |
| 80061 | Lipid panel | <1% | 4,890 | $3K |
| 87449 | <1% | 342 | $3K | |
| 80050 | General health panel | <1% | 123 | $2K |
| 82043 | <1% | 426 | $2K | |
| 85384 | <1% | 241 | $2K | |
| ATP05 | <1% | 203 | $2K | |
| 82565 | <1% | 1,870 | $1K | |
| 88112 | <1% | 129 | $1K | |
| 88311 | <1% | 298 | $1K | |
| 84153 | <1% | 85 | $1K | |
| ATP06 | <1% | 142 | $1K | |
| 82550 | <1% | 1,656 | $1K | |
| 80074 | <1% | 72 | $1K | |
| 86706 | <1% | 57 | $1K | |
| 85014 | <1% | 694 | $791.02 | |
| 86255 | <1% | 82 | $754.16 | |
| 85018 | <1% | 600 | $666.88 | |
| ATP23 | <1% | 45 | $571.05 | |
| 84156 | <1% | 163 | $498.96 | |
| ATP11 | <1% | 50 | $462.00 | |
| 88173 | <1% | 19 | $456.33 | |
| 83615 | <1% | 1,502 | $439.32 | |
| 84132 | <1% | 1,036 | $433.71 | |
| 85049 | <1% | 127 | $343.53 | |
| 86077 | <1% | 12 | $318.24 | |
| 84480 | <1% | 28 | $286.90 | |
| 86256 | <1% | 27 | $255.76 | |
| 82248 | <1% | 1,962 | $249.82 | |
| 84520 | <1% | 1,008 | $239.47 | |
| 84146 | <1% | 14 | $226.26 | |
| 82378 | <1% | 13 | $217.36 | |
| 83970 | <1% | 12 | $216.00 | |
| 82533 | <1% | 13 | $215.70 | |
| 86334 | <1% | 25 | $212.61 | |
| 80164 | <1% | 29 | $198.81 | |
| ATP19 | <1% | 13 | $150.41 | |
| 86787 | <1% | 14 | $119.66 | |
| ATP10 | <1% | 13 | $118.17 | |
| 85060 | <1% | 13 | $117.54 | |
| 85045 | <1% | 42 | $116.98 | |
| 86762 | <1% | 13 | $110.97 | |
| 82247 | <1% | 603 | $110.75 | |
| 84300 | <1% | 13 | $53.52 | |
| 82040 | <1% | 74 | $45.62 | |
| 88300 | <1% | 24 | $44.14 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 36 | $40.00 |
| 84550 | <1% | 523 | $33.61 | |
| 84460 | <1% | 315 | $21.89 | |
| 84478 | <1% | 111 | $20.24 | |
| 80051 | <1% | 62 | $17.35 | |
| 84450 | <1% | 222 | $1.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCALLUM, MICHAEL (CEO OF STEWARD PHYSICIAN NETWORK)
Parent organizationSTEWARD HEALTH CARE SYSTEM LLC
| Provider | Location | Paid |
|---|---|---|
| Steward Emergency Physicians, INC | Ayer, MA | $58.82M |
| Steward Medical Group, INC | Dartmouth, MA | $34.64M |
| Steward Medical Group, INC | Brighton, MA | $8.35M |
| Steward Medical Group, INC | Boston, MA | $3.53M |
| Urology Consultants of NS | Salem, MA | $394K |
| Steward Medical Group, INC. | Brighton, MA | $225K |
| Steward Medical Group, INC | Dartmouth, MA | $142K |
| Steward Radiology Physicians of Pennsylvania INC | Sharon, PA | $253.35 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.